
The results of clinical experimental with a new antibiotic, Miocamycin (Macroral Zambeletti), are reported. 300 patients suffering from the most varied infections of the oral cavity were treated. In view of its utility and the lack of side-effects, it is concluded that this antibiotic may be used with peace of mind in odontostomatological pathology.
Humans, Pulpitis, Cellulitis, Miocamycin, Infections, Mouth Diseases, Leucomycins, Periodontal Diseases
Humans, Pulpitis, Cellulitis, Miocamycin, Infections, Mouth Diseases, Leucomycins, Periodontal Diseases
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
